1. Astedt B, Lecander I, Ny T (1987) The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1: 203–208
2. Bachmann F (1987) Fibrinolysis. In: Verstraete M, Vermylen J, Lijnen HR, Arnout J (eds) Thrombosis and Haemostasis. International Society on Thrombosis and Haemostasis and Leuven University Press, Leuven, pp. 227–265
3. Beckmann R, Geiger M, Binder BR (1988) Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr-fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation. J Biol Chem 263: 7176–7180
4. Behrendt N, Ronne E, Ploug M, Petri T, Lober D, Nielsen LS, Schleuning W-D, Blasi F, Appella E, Dano K (1990) The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem 265: 6453–6460
5. Berrettini M, Schleef RR, Espana F, Loskutoff DJ, Grffin JH (1989) Interaction of type 1 plasminogen activator inhibitor with the enzymes of the contact activation system. J Biol Chem 264: 11738–11743